01 · Equity deep-dive — synthesized analyst desk
CRM
$246.74 ▼ 8% off Dec ’25 high
NYSE · ENTERPRISE SOFTWAREMKT CAP ≈ $203B52-WK $146.32 – $269.11AS OF OCT 15, 2026 CLOSE

The funnel is re-accelerating. The stock still prices a seat that may disappear.

Salesforce is going headless: Agentforce, Slackbot and “Claudeforce” let agents work the record without a human screen. cRPO growth accelerated to 14% and the stock jumped about 23% on Aug 27, yet it sits far below its Dec 2024 peak. The market is pricing one question: when the interface dissolves, does the system of record keep the toll?

The verdict · TL;DR
Core debate: do AI agents consume Salesforce’s record (and pay for it), or route around it and shrink the seat count? Operating momentum is real — cRPO +14%, 34% non-GAAP margin, ~$15B FCF — but reported EPS is padded by Anthropic-stake gains, and $25B of debt now funds the buyback. The setup is positive-skew, yet leveraged to one answer.
5-yr · prob-weighted
52-week tape · where the price sitsTRADING IN THE UPPER THIRD
$246.74 · Oct 15, 2026consensus $285.68 · +16%
$146.32 · low, Jun 22 ’26$269.11 · high, Dec 29 ’25
Price history + cone of outcomes · Oct 2024 → Oct 2031
HISTORICALBULLBASEBEARPROB-WTD

Gray = actual month-end closes (Oct 2024–Sep 2026, plus Oct 15 close); dots mark intraday 52-week extremes. Log price axis. Colored paths = scenario midpoints at +1/+2/+3/+5 years; clay circle = Street 12-month consensus ($285.68). Scenario weights 30/45/25 bear/base/bull — tilted bear because the AI-disintermediation outcome is binary and the balance sheet is now levered.

Re-weight the scenarios

Drag bear and bull (base takes the remainder). The blended target, dotted chart line and prob-weighted card rows update live.

Blended 5-yr expected
$11.35BQ2 FY27 revenue · +11% (Informatica $456M)
+14%cRPO $33.5B · constant currency
34.1%Non-GAAP operating margin
$1.1BQ2 free cash flow · +81%
$3.9BAgentforce + Data 360 ARR · +210%
$1.5BAgentforce ARR · +240%
$15.2BTTM free cash flow
$16.69FY27 non-GAAP EPS guide (midpoint, incl. gains)
02 · The panel

Four analyst lenses, four answers

Synthesized perspectives, each with its own 12-month target built as EPS × multiple.

Growth PM · conviction high

The Compounder

cRPO re-accelerating to 14%, Agentforce ARR up 240%, Slack at its fastest bookings growth since acquisition, and management guiding to a second-half organic re-acceleration. Core-plus-AI deserves a market multiple, not a distressed one.

12-MO TARGET $300 · ~19.5x FY28E $15.4
Value / FCF · conviction medium

The Cash Counter

~$15.2B trailing FCF on a $203B cap is a ~7.5% yield for a business growing 11%. The ASR has already retired over 100M shares. Net debt of roughly $28B is covered by that cash flow and a stake in Anthropic management says it may sell.

12-MO TARGET $285 · ≈ Street consensus
AI Disruption Skeptic · conviction medium

The Seat Squeeze

Per-seat software shrinks when agents do the work, and frontier labs (Anthropic, Meta) are moving into enterprise workflows. Reported EPS leans on investment gains; strip them and the multiple is not cheap. Flat EPS and a de-rating to ~13x gets you the June lows.

12-MO TARGET $179 · 13x on $13.8
Balance-Sheet Analyst · conviction medium

The Leverage Check

Debt went from about $14B to about $39B in two quarters; book equity is smaller than goodwill. Interest cut FY27 FCF growth guidance from 9–10% to 4–5%. Fine at today’s cash flow, unforgiving if growth stalls. Fair value near the Morgan Stanley neighborhood.

12-MO TARGET $240 · ~15.5x FY28E
03 · Wall Street’s read

Sell-side 12-month price targets

Selected firms, sorted low to high. The dashed line is today’s $246.74.

Consensus ≈ $285.68 (+16%) · 56 analysts, rated Buy
BUYHOLDSELL

Targets and ratings as reported Aug 27–Oct 12, 2026 (BofA double-upgrade to Buy on Oct 12, $160→$285). Aggregators disagree on the mean: stockanalysis $285.68, MarketBeat $278.12, TipRanks $277.47 (range $165–$400). No sell-rated firm target was verified, so none is charted.

04 · Price scenarios — 1 / 2 / 3 / 5 years

Where the funnel leads

Each price is in-year clean EPS × exit multiple. Returns are versus $246.74. Illustrative frameworks, not forecasts.

Bull case — assumptions & math
Agents run on Salesforce data (AIforce, Claudeforce), seats convert to consumption, bookings compound mid-teens, margin expands, and buybacks shrink the count.FY32 EPS ≈ $29.8 × 24x → $715 · EPS CAGR ≈ 17%
Base case — assumptions & math
Revenue grows ~10–11% toward the $63B FY30 target, non-GAAP margin drifts up, buybacks offset interest, multiple holds near today’s ~18x clean.FY32 EPS ≈ $24.2 × 18x → $436 · EPS CAGR ≈ 12%
Bear case — assumptions & math
Seat compression and model-vendor bypass flatten growth; buybacks only offset interest and dilution; the multiple returns to the June-2026 trough zone.FY32 EPS ≈ $15.0 × 12x → $180 · 5-yr CAGR ≈ −6%
Why “clean” EPS?
FY27 non-GAAP guidance of $16.67–16.71 includes Q1–Q2 gains on strategic investments (Q2 alone: $2.6B pre-tax, tied to the Anthropic stake). Stripping roughly $3.1/share of gains gives ~$13.6 clean (my estimate), so the stock trades near 18x, not the 14.8x headline.$246.74 / $13.6 ≈ 18.1x · vs 14.8x on $16.69 reported
05 · Follow the cash

Revenue, capex, free cash flow & debt ($B)

The bull and bear theses both live in the gap between the FCF bar and the debt bar.

Annual revenue, capex, FCF & debt · FY25 → FY27E
REVENUECAPEXFREE CASH FLOWTOTAL DEBT

FY25–FY26 from 8-K Ex. 99.1 (Feb 25, 2026): revenue $37.9B/$41.5B, capex $0.66B/$0.59B, FCF $12.4B/$14.4B, debt $8.4B/$14.4B. FY27E: revenue guide midpoint $46.25B, capex ~1.5% of revenue, FCF ~+4.5% (management: ~$15B). FY27E debt is the Jul 31, 2026 actual: $33.3B notes + $6.0B term loan (10-Q). Capex is tiny; the risk is the $25B debt-funded ASR, not asset intensity.

06 · Earnings power

EPS path underpinning the targets ($)

Non-GAAP EPS excluding strategic-investment gains: the ladder the base case is built on.

Clean non-GAAP EPS · FY25 → FY32E
REPORTED, EX-GAINSESTIMATE (BASE)

FY25 reported $10.20 (includes a $0.10 loss, so $10.30 clean); FY26 reported $12.52 (includes $0.83 of gains, so $11.69 clean). FY27E ~$13.6 is my estimate (guide $16.69 less ~$3.1 of gains). FY28E onward is the base case at ~13% growth. Fiscal years end January.

07 · Growth scorecard

The business is still growing

Q2 FY27, year over year. Core lines in olive, frontier AI/data lines in clay.

YoY growth by metric · Q2 FY27
COREFRONTIER

Revenue +11%, cRPO +14% (cc), FCF +81%, AI+Data ARR +210%, Agentforce ARR +240%, Data 360 records ingested +355%. Frontier lines grow off small bases ($3.9B of ARR against $46B of revenue); organic revenue growth still needs the guided second-half re-acceleration to show up.

08 · The debate

Bull vs. Bear

Is Salesforce the system of record agents must pass through, or the seat license they make unnecessary?

▲ THE BULL CASE

  • Bookings are accelerating. cRPO +14% cc, near-record-low attrition, and Q3 guided to ~14% before two pending deals.
  • AI is now a real line. $3.9B ARR, Agentforce bookings in premium editions more than doubled Q/Q.
  • Cash machine. ~$15B FCF; $60B+ cumulative buybacks; dividend raised 5.8%.
  • Frontier labs as partners. Claudeforce and AIforce make Salesforce data the thing agents call; Anthropic reported 1.5M actions in a month.
  • Long-range targets above the Street. $63B+ FY30 revenue vs $59.2B LSEG consensus.
  • Optionality. Management says it will likely sell the Anthropic stake to repay buyback debt.

▼ THE BEAR CASE

  • Seat compression. Agents doing the work reduce the licenses a per-seat model depends on.
  • Organic growth is ~8%. Informatica adds about 3 points; reported 11% is not organic.
  • EPS quality. Q2 non-GAAP EPS +103% includes a $2.6B investment gain; clean EPS is far smaller.
  • Leverage. Debt up ~$25B; FY27 FCF growth guidance halved; book equity below goodwill.
  • Platform risk. Anthropic and Meta moving into enterprise workflows can bypass the interface.
  • M&A churn. Informatica integration plus pending Contentful and Fin deals.
09 · Risk map

Risk map — likelihood × impact

Over a 3–5 year horizon. The hot corner is likely and high-impact.

Low impact
Medium
High impact
Likely
GAAP noise
Debt burden
Sector de-rating
Seat compression
Possible
M&A churn
Model-vendor bypass
Tail
Agent data breach

Seat compression

Likely × High

Agents replace human seats faster than consumption pricing replaces the revenue.

Model-vendor bypass

Possible × High

Frontier labs own the interface and route work around Salesforce’s record.

Agent data breach

Tail × High

A major incident in agent access to customer data stalls enterprise rollouts and reprices trust.

Debt burden

Likely × Medium

~$39B of debt at a higher fixed cost leaves less room if growth slows.

Sector de-rating

Likely × Medium

Software sentiment swings; the stock fell to $146 in June despite rising estimates.

M&A churn

Possible × Medium

Integration of Informatica, Contentful and Fin distracts from organic re-acceleration.

GAAP noise

Likely × Low

Investment mark-to-market swings headline EPS in both directions.

10 · Plain-language glossary

The jargon, decoded

Hover the dotted terms above, or scan these definitions.

cRPO
Contracted revenue Salesforce expects to recognize within 12 months — the best leading read on near-term growth.
Agentforce ARR
Annualized value of active AI-agent subscriptions at period end. Since Q2 it includes Slackbot and Headless 360.
Headless
Software whose data and workflows are used by agents through APIs, with no human screen required.
ASR
Accelerated share repurchase: a block buyback paid up front, here $25B funded by new debt, with 103M shares delivered immediately.
FCF yield
Free cash flow ÷ market cap. About 7.5% here.
Non-GAAP EPS
Earnings excluding stock comp, amortization and restructuring. Salesforce leaves investment gains in, which is why we strip them.
Exit multiple
The P/E assumed at the horizon. Multiply by that year’s EPS to get the target price.
Prob-weighted
Each scenario price times its probability, summed into one expected value.